Your browser doesn't support javascript.
loading
Switching to lopinavir/ritonavir with or without abacavir/lamivudine in lipoatrophic patients treated with zidovudine/abacavir/lamivudine.
Bernardino, J I; Pulido, F; Martinez, E; Arrizabalaga, J; Domingo, P; Portilla, J; Ocampo, A; Muñoz, J; Torres, R; Arribas, J R.
Affiliation
  • Bernardino JI; Hospital Universitario La Paz, IdiPAZ, Madrid, Spain. jibernardino.hulp@salud.madrid.org
J Antimicrob Chemother ; 68(6): 1373-81, 2013 Jun.
Article in En | MEDLINE | ID: mdl-23386261
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Dideoxynucleosides / HIV Infections / Adipose Tissue / HIV Protease Inhibitors / Reverse Transcriptase Inhibitors / Ritonavir / Lamivudine / Antiretroviral Therapy, Highly Active / Lopinavir / Lipodystrophy Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Antimicrob Chemother Year: 2013 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Dideoxynucleosides / HIV Infections / Adipose Tissue / HIV Protease Inhibitors / Reverse Transcriptase Inhibitors / Ritonavir / Lamivudine / Antiretroviral Therapy, Highly Active / Lopinavir / Lipodystrophy Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Antimicrob Chemother Year: 2013 Document type: Article